SOTRADECOL Drug Patent Profile
Which patents cover Sotradecol, and when can generic versions of Sotradecol launch?
Sotradecol is a drug marketed by Elkins Sinn and Mylan Institutional and is included in two NDAs.
The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sotradecol
A generic version of SOTRADECOL was approved as sodium tetradecyl sulfate by HIKMA on December 9th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SOTRADECOL?
- What are the global sales for SOTRADECOL?
- What is Average Wholesale Price for SOTRADECOL?
Summary for SOTRADECOL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,929 |
| DailyMed Link: | SOTRADECOL at DailyMed |
Recent Clinical Trials for SOTRADECOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| American Rhinologic Society | Phase 1/Phase 2 |
| University of Minnesota - Clinical and Translational Science Institute | Phase 1/Phase 2 |
| University of Minnesota | Phase 1/Phase 2 |
US Patents and Regulatory Information for SOTRADECOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elkins Sinn | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 005970-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Institutional | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 040541-002 | Nov 12, 2004 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Elkins Sinn | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 005970-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Institutional | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 040541-001 | Nov 12, 2004 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
